RVL Pharmaceuticals plc Goodwill

RVL Pharmaceuticals plc (RVLP) currently reports a goodwill of $56M as of June 2023. That compares with $56M in the prior-year period — up 0.0% year over year. Use the charts on this page to explore RVL Pharmaceuticals plc's goodwill history and peer comparisons.

RVL Pharmaceuticals plc's goodwill was unchanged from $56M to $56M — essentially flat versus a year earlier (period ending June 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

RVL Pharmaceuticals plc reported $56M in goodwill as of June 2023. That compares with $56M in the prior-year period — up 0.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current goodwill of $56M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for RVL Pharmaceuticals plc, and consider following RVLP for alerts when major investors trade the stock.

RVL Pharmaceuticals plc is classified in the Healthcare sector. On goodwill, it currently shows $56M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing RVLP with unrelated industries.